05.10.2006 15:57:00
|
Accenture and Edge Dynamics Launch Next Phase of Channel Commerce Management Initiative for Bristol-Myers Squibb
NEW YORK and REDWOOD CITY, Calif., Oct. 5 /PRNewswire/ -- Accenture and Edge Dynamics, the leading provider of channel commerce management (CCM) solutions, today announced that they will implement the next phase of their work for Bristol-Myers Squibb .
This collaboration represents the first project for Accenture and Edge Dynamics under their new alliance with Accenture to deliver Edge Dynamics' enterprise software solutions to the life sciences industry in North America.
Deployed at leading pharmaceutical manufacturers, the Edge Dynamics CCM solution enhances corporate performance by enabling manufacturers to more effectively manage distribution channel operations. The Accenture and Edge Dynamics teams bring both the industry and technology experience to help achieve this important initiative.
The Accenture project team will implement the next phase of the Edge Dynamics CCM solution to enhance the channel commerce management system between Bristol-Myers Squibb channel partners and the company's SAP enterprise resource planning system. This project builds upon the work started by Edge Dynamics in 2005.
"We are pleased to team with Edge Dynamics on this project as we work together to help leading pharmaceutical companies enhance their channel management capabilities," said Jamie Hintlian, a partner in Accenture's Health & Life Sciences practice.
"Edge Dynamics and Accenture share a common vision for this alliance, and we are fully committed to help manufacturers achieve improved corporate performance through strong operations and improved visibility into the distribution channel," said Henry Olson, president and CEO of Edge Dynamics. "With its deep industry experience in the life sciences industry, and an outstanding ability to combine technology with business processes, Accenture will complement Edge Dynamics' offerings to provide customers with a complete solution."
About Accenture
Accenture is a global management consulting, technology services and outsourcing company. Committed to delivering innovation, Accenture collaborates with its clients to help them become high-performance businesses and governments. With deep industry and business process expertise, broad global resources and a proven track record, Accenture can mobilize the right people, skills, and technologies to help clients improve their performance. With approximately 140,000 people in 48 countries, the company generated net revenues of US$16.65 billion for the fiscal year ended Aug. 31, 2006. Its home page is http://www.accenture.com/ .
About Edge Dynamics
Edge Dynamics is the pioneer and leading provider of channel commerce management (CCM) solutions to the life sciences industry. Edge Dynamics uniquely provides a full range of on-premise, hosted and hybrid solutions that enable manufacturers to optimize their transaction stream processing to address critical business challenges in the areas of operations performance, regulatory compliance, and brand integrity. Deployed at leading pharmaceutical manufacturers, the Edge Dynamics enterprise software solution currently optimizes more than $100 billion in annual channel revenues. Edge Dynamics has offices in Redwood City, California, and Philadelphia, Pennsylvania. For more information, visit http://www.edgedynamics.com/ , send email to info@edgedynamics.com, or call 1-866-737-EDGE.
NOTE: Edge Dynamics and the Edge Dynamics logo are trademarks of Edge Dynamics, Inc. in the United States and other countries. All other company and product names mentioned are the trademarks or registered trademarks of their respective companies.
Contact: Marykate Reese of Accenture, +1-917-452-8738, or Marykate.reese@accenture.com; or Scott Bauman of Greenough Communications, +1-617-275-6518, or sbauman@greenoughcom.com, for Edge Dynamics/
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Accenture plcmehr Nachrichten
09:52 |
Kion, Nvidia, Accenture mit KI-Lieferketten-Optimierung - Kion-Aktie +9% (Dow Jones) | |
03.01.25 |
S&P 500-Wert Accenture-Aktie: So viel Gewinn hätte eine Accenture-Investition von vor einem Jahr eingebracht (finanzen.at) | |
27.12.24 |
S&P 500-Titel Accenture-Aktie: So viel Gewinn hätte ein Investment in Accenture von vor 10 Jahren eingebracht (finanzen.at) | |
25.12.24 |
Generative KI: Warum der NVIDIA-CEO auf Accenture setzt (finanzen.at) | |
20.12.24 |
Freundlicher Handel: S&P 500 mit Kursplus (finanzen.at) | |
20.12.24 |
S&P 500-Titel Accenture-Aktie: So viel Gewinn hätte ein Accenture-Investment von vor 5 Jahren abgeworfen (finanzen.at) | |
19.12.24 |
NYSE-Handel S&P 500 fällt zum Ende des Donnerstagshandels zurück (finanzen.at) | |
19.12.24 |
Börse New York: S&P 500 bewegt sich am Nachmittag im Plus (finanzen.at) |
Analysen zu Accenture plcmehr Analysen
Aktien in diesem Artikel
Accenture plc | 343,00 | 1,09% | |
Bristol-Myers Squibb Co. | 54,40 | -0,31% |
Indizes in diesem Artikel
S&P 500 | 5 934,05 | -0,69% | |
S&P 100 | 2 914,19 | -0,96% | |
NYSE US 100 | 16 447,86 | 0,76% |